Overview
Bioequivalence studies are essential for ensuring that generic medicines meet the same standards of safety, quality, and effectiveness as innovator products. VIBRI provides scientifically rigorous bioequivalence research that supports regulatory approvals and strengthens pharmaceutical access across Africa.
Our work supports governments, regulators, and manufacturers in expanding access to affordable, high-quality medicines while maintaining international standards.
What We Do
- Comparative bioavailability and bioequivalence studies
- Regulatory-compliant study design and execution
- Pharmacokinetic and statistical analysis
- Quality assurance and reporting aligned with global standards
Why It Matters
Bioequivalence research enables:
Faster approval of generic medicines
Reduced healthcare costs
Strengthened local pharmaceutical production
Improved medicine availability for public health programs
Impact
- Increased access to affordable essential medicines
- Evidence-based regulatory decision-making
- Strengthened national medicine supply chains
Partner With Us
Collaborate with VIBRI to support medicine access through high-quality bioequivalence research that meets regulatory and public health priorities.